Drug Patent Expirations for the week of March 11, 2012
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| NUTROPIN DEPOT | Genentech | somatropin recombinant | 5,912,015 | Mar 12, 2012 | |||||
| LEXAPRO | Forest Labs | escitalopram oxalate | RE34712*PED | Mar 14, 2012 | |||||
| BONIVA | Roche | ibandronate sodium | 4,927,814 | Mar 17, 2012 | |||||
| AVANDIA | Sb Pharmco | rosiglitazone maleate | 5,002,953*PED | Mar 17, 2012 | |||||
| AVANDARYL | Sb Pharmco | glimepiride; rosiglitazone maleate | 5,002,953*PED | Mar 17, 2012 | |||||
| AVANDAMET | Sb Pharmco | metformin hydrochloride; rosiglitazone maleate | 5,002,953*PED | Mar 17, 2012 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
Tentative Approvals
| Ingredient | Tentative Approvals | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| escitalopram oxalate | 18 | ||||||||
| ibandronate sodium | 7 | ||||||||
| rosiglitazone maleate | 7 | ||||||||
*Tentative approvals are indicators of potential future generic entry. See the DrugPatentWatch database for complete details.
| |||||||||
No comments:
Post a Comment